{"product_id":"cjc-1295-no-dac","title":"CJC-1295 (NO DAC)","description":"\u003cp\u003e\u003cstrong\u003eCJC-1295 (No DAC)\u003c\/strong\u003e is a research peptide related to growth hormone-releasing hormone (GHRH), the signaling molecule that helps regulate growth-hormone release from the pituitary. Researchers study the No-DAC form to examine this signaling without the extended-action DAC modification.\u003c\/p\u003e\u003cp\u003eMore specifically, research involving CJC-1295 (No DAC) examines GHRH-receptor activity, pituitary signaling, growth-hormone release, peptide structure, and the broader growth hormone \/ IGF-1 research axis.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eTechnical Identity:\u003c\/strong\u003e CJC-1295 (No DAC) is commonly characterized as a modified GHRH(1-29)-related peptide without the Drug Affinity Complex (DAC) extension used in longer-acting CJC-1295 forms.\u003c\/p\u003e\u003cp\u003eAzyven Research CJC-1295 (No DAC) is supplied exclusively for laboratory research and analytical use.\u003c\/p\u003e\n\n\u003ch3\u003eWhat is CJC-1295 (No DAC)?\u003c\/h3\u003e\u003cp\u003eCJC-1295 (No DAC) is a synthetic GHRH-related research peptide. The “No DAC” designation distinguishes this form from longer-acting CJC variants that incorporate a Drug Affinity Complex designed to extend persistence.\u003c\/p\u003e\u003ch3\u003eWhy is CJC-1295 (No DAC) studied?\u003c\/h3\u003e\u003cp\u003eCJC-1295 (No DAC) has attracted research interest because GHRH is one of the body's central signals for growth-hormone release from the pituitary.\u003c\/p\u003e\u003cp\u003eResearchers study GHRH-related peptides to understand receptor activation, hormone-release patterns, peptide stability, and downstream signaling involving IGF-1 and other endocrine processes.\u003c\/p\u003e\u003ch3\u003eWhat research areas are associated with CJC-1295 (No DAC)?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eGHRH-Receptor Research\u003c\/strong\u003e\u003cbr\u003eCJC-1295 (No DAC) is studied in connection with activation of the GHRH receptor.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eGrowth-Hormone Signaling Research\u003c\/strong\u003e\u003cbr\u003eResearch examines how GHRH-related signals influence pituitary growth-hormone release.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eGrowth Hormone \/ IGF-1 Axis Research\u003c\/strong\u003e\u003cbr\u003eResearchers investigate downstream endocrine signaling associated with growth-hormone activity.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePeptide-Structure Research\u003c\/strong\u003e\u003cbr\u003eThe No-DAC form is useful for studying how structural modifications influence peptide duration and biological behavior.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eEndocrine-Signaling Research\u003c\/strong\u003e\u003cbr\u003eCJC-related research contributes to broader understanding of hypothalamic-pituitary signaling and hormone regulation.\u003c\/p\u003e\u003ch3\u003eWhat have studies found?\u003c\/h3\u003e\u003cp\u003eResearch involving CJC-related and GHRH analogues has explored receptor activity, hormone signaling, and peptide pharmacology.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eGHRH-receptor activity\u003c\/strong\u003e\u003cbr\u003eStudies support the use of GHRH analogues as tools for investigating pituitary growth-hormone signaling.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eGrowth-hormone and IGF-1 signaling\u003c\/strong\u003e\u003cbr\u003eResearch on CJC compounds has reported changes involving growth hormone and downstream IGF-1 biology.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePeptide duration\u003c\/strong\u003e\u003cbr\u003eStudies of CJC variants demonstrate that structural modifications can substantially affect how long related peptides persist and signal.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eEvidence context\u003c\/strong\u003e\u003cbr\u003eDAC-modified CJC-1295 and No-DAC forms are not interchangeable, so findings involving one molecular form should not automatically be attributed to the other.\u003c\/p\u003e\u003ch3\u003eHow does CJC-1295 (No DAC) relate to other Azyven products?\u003c\/h3\u003e\u003cp\u003eCJC-1295 (No DAC) is available as a standalone research peptide and is also a component of Azyven's \u003cstrong\u003eCJC-1295 \/ Ipamorelin Blend\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003eResearchers may compare it with \u003cstrong\u003eSermorelin\u003c\/strong\u003e and \u003cstrong\u003eTesamorelin\u003c\/strong\u003e, which also involve GHRH-receptor biology, or with \u003cstrong\u003eIpamorelin\u003c\/strong\u003e, which approaches growth-hormone signaling through the ghrelin receptor.\u003c\/p\u003e\u003cp\u003eResearchers can ask Aria Jr. to compare these signaling pathways and research formats.\u003c\/p\u003e\u003ch3\u003eWhat am I purchasing?\u003c\/h3\u003e\u003cp\u003eAzyven Research CJC-1295 (No DAC) is supplied as a lyophilized research material in the strength selected above.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAvailable Strengths:\u003c\/strong\u003e 5 mg and 10 mg\u003cbr\u003e\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilized powder\u003cbr\u003e\u003cstrong\u003eProduct Type:\u003c\/strong\u003e Research Peptide\u003cbr\u003e\u003cstrong\u003eIntended Use:\u003c\/strong\u003e Laboratory research only\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Use Only:\u003c\/strong\u003e Azyven Research products are intended for laboratory research purposes only. They are not intended for human or veterinary use, consumption, administration, or clinical application.\u003c\/p\u003e","brand":"Azyven Research","offers":[{"title":"5 MG","offer_id":60251460501585,"sku":"CND5","price":49.99,"currency_code":"USD","in_stock":true},{"title":"10 MG","offer_id":62595112894545,"sku":"CND10","price":69.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1069\/8869\/9729\/files\/CJC-1295_NODAC.png?v=1788109824","url":"https:\/\/azyvenresearch.com\/products\/cjc-1295-no-dac","provider":"Azyven Research ","version":"1.0","type":"link"}